Hims & Hers Health, INC Form 4 insider transactions
NYSE
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., acquired 193,584 Restricted Stock Units (RSUs) on February 28, 2024, according to a Form 4 filing with the SEC.
NYSE
Form 4: Hims & Hers Health CEO Andrew Dudum Executes Stock Options and Sells Shares Under 10b5-1 Plan
Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock on February 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Director David B. Wells sold 260,000 shares of Hims & Hers Health, Inc. at an average price of $13.1585 on February 28, 2024.
NYSE
Irene Becklund, PAO of Hims & Hers Health, sold 2,747 shares of Class A Common Stock at $12.08 per share on February 27, 2024, under a pre-arranged 10b5-1 trading plan.